Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries

The increasing availability of biosimilar medicines in Middle Eastern regions may provide an opportunity to increase the number of rheumatology patients who have access to traditionally more expensive biologic medicines. However, as well as a lack of real-world data on the use of biosimilar medicine...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Rheumatol
Asıl Yazarlar: El Zorkany, Bassel, Al Ani, Nizar, Al Emadi, Samar, Al Saleh, Jamal, Uthman, Imad, El Dershaby, Yasser, Mounir, Mohamed, Al Moallim, Hani
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer London 2018
Konular:
Review Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5913383/
https://ncbi.nlm.nih.gov/pubmed/29411181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-018-3982-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller